{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:55:50Z","timestamp":1778169350391,"version":"3.51.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/wnf.0000000000000099","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T13:36:25Z","timestamp":1442064985000},"page":"204-205","source":"Crossref","is-referenced-by-count":6,"title":["Unique Scopolamine Withdrawal Syndrome After Standard Transdermal Use"],"prefix":"10.1097","volume":"38","author":[{"given":"Maurizio","family":"Manno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Sbordone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Matteis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"3","key":"R1-7-20210203","first-page":"CD002851","article-title":"Scopolamine for preventing and treating motion sickness.","author":"Spinks","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0079-6123(08)64698-1","article-title":"Effects of scopolamine and pilocarpine on the activity of acetylcholinesterase in rat brain synaptosomal fractions.","volume":"49","author":"Venkov","year":"1979","journal-title":"Prog Brain Res"},{"issue":"5","key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0091-3057(84)90198-9","article-title":"Chronic scopolamine treatment and brain cholinergic function.","volume":"20","author":"Marks","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00325481.1990.11704520","article-title":"Scopolamine withdrawal syndrome.","volume":"87","author":"Saxena","year":"1990","journal-title":"Postgrad Med"},{"issue":"22","key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"202420096","DOI":"10.2146\/ajhp080569","article-title":"Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.","volume":"66","author":"Patel","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"e32082","DOI":"10.1371\/journal.pone.0032082","article-title":"Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems.","volume":"7","author":"Falsafi","year":"2012","journal-title":"PLoS One"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(80)90973-7","article-title":"Scopolamine induces an increase in muscarinic receptor level in rat hippocampus.","volume":"193","author":"Ben-Barak","year":"1980","journal-title":"Brain Res"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1124\/dmd.108.024810","article-title":"Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.","volume":"37","author":"Stringer","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.ftd.0000168293.48226.57","article-title":"Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.","volume":"27","author":"Renner","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-0447.1985.tb01287.x","article-title":"Withdrawal of trihexyphenidyl.","volume":"71","author":"Micinnis","year":"1985","journal-title":"Acta Psychiatr Scand"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0033-3182(84)72999-9","article-title":"Cholinergic syndrome from psychotropic withdrawal in a marijuana abuser.","volume":"25","author":"Dilsaver","year":"1984","journal-title":"Psychosomatics"},{"key":"R12-7-20210203","first-page":"3","article-title":"Anticholinergic to treat clozapine withdrawal.","volume":"55","author":"de Leon","year":"1994","journal-title":"J Clin Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:10:19Z","timestamp":1620976219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201509000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000099","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}